Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing

1 Jan 2024

Abstract excerpt

Abstract Multiple sclerosis is a chronic demyelinating disease of the central nervous system. There is a need for new circulating biomarkers for multiple sclerosis, in particular, markers that differentiate multiple sclerosis subtypes (relapsing–remitting, secondary progressive and primary progressive multiple sclerosis), as this can help in making treatment decisions. In this study, we explore two classes of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Multiple Sclerosis Research Studies
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38978729
DOI: 10.1093/braincomms/fcae209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencingPMID 38978729Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

Novel plasma and brain proteins that are implicated in multiple sclerosisSemantic proximity Read ↗

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read ↗

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosisSemantic proximity Read ↗

Circulating microRNAs as biomarkers in progressive multiple sclerosisSemantic proximity Read ↗

Comparing Single-Cell Transcriptomes of Blood and Cerebrospinal Fluid Leukocytes in Multiple SclerosisSemantic proximity Read ↗

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read ↗

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read ↗

Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controlsSemantic proximity Read ↗

The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistanceSemantic proximity Read ↗

miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisSemantic proximity Read ↗

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.